Skip to Content
Top of Page: How to talk to a doctor about advanced ovarian cancer >>

Mitotane Pregnancy and Breastfeeding Warnings

Mitotane is also known as: Lysodren

Mitotane Pregnancy Warnings

Abnormal pregnancy outcomes such as preterm births, early pregnancy loss, fetal adrenal abnormalities have been reported in patients exposed to this drug during pregnancy. Animal reproduction studies with this drug have not been conducted, but animal studies with similar substances have shown evidence of reproductive toxicity. US FDA pregnancy category D: There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug can cause fetal harm; it should be used during pregnancy only if clearly needed and the benefit outweighs the risk to the fetus. US FDA pregnancy category: D Comments: Women of childbearing potential should be advised not to get pregnant during therapy due to the potential hazard to a fetus/potential risk for pregnancy loss, and they should use effective contraception during treatment and after treatment discontinuation for as long as plasma levels of this drug are detectable.

See references

Mitotane Breastfeeding Warnings

-Breastfeeding is contraindicated during treatment and after treatment cessation for as long as plasma levels of this drug are detectable. (UK) -Breastfeeding should be discontinued during treatment and after treatment cessation for as long as plasma levels of this drug are detectable. (US) Excreted into human milk: Yes Comments: The effects in the nursing infant are unknown.

See references

References for pregnancy information

  1. "Product Information. Lysodren (mitotane)." Bristol-Myers Squibb, Princeton, NJ.

References for breastfeeding information

  1. "Product Information. Lysodren (mitotane)." Bristol-Myers Squibb, Princeton, NJ.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide